
    
      This will be a single center, eight week, randomized, controlled, examiner blind, four
      treatment arm, parallel design, stratified (by maximum baseline Schiff Sensitivity Score of
      the two selected test teeth), exploratory study in participants with at least two sensitive
      teeth that meet all the criteria at the Screening and Baseline visit. Participants will be
      assessed at Baseline, four and eight weeks to monitor clinical efficacy and safety.
    
  